Wuhan Jinyintan Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huang, Chaolin
NCT05582629: JT001 (VV116) for the Treatment of COVID-19

Completed
3
1369
RoW
JT001, VV116, Placebo
Shanghai Vinnerna Biosciences Co., Ltd., Sponsor GmbH
Mild to Moderate COVID-19
02/23
02/23
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
2
140
RoW
UC-MSCs, Placebo(solution without UC-MSCs)
Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital
Decompensated Cirrhosis
06/25
06/27
NCT06038916: To Evaluate the Safety and Initial Efficacy of STSA-1002 Injection in Patients with Acute Respiratory Distress Syndrome

Recruiting
1/2
60
RoW
STSA-1002 Injection Placebo, STSA-1002 Injection
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Acute Respiratory Distress Syndrome
08/25
09/26
NCT04883177: Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Completed
N/A
1000
RoW
Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Huashan Hospital, The Sixth People's Hospital of Shenyang City, Xingtai City People's Hospital, Jinchang Central Hospital, Baoding People's Hospital, The Third People's Hospital of Zhenjiang City, Shanxi Bethune Hospital, Wuhan Jinyintan Hospital, Jincheng People's Hospital, The Third People's Hospital of Tibet Autonomous Region, People's Hospital of Ningxia Hui Autonomous Region, Fuling Central Hospital of Chongqing City, Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, The Central Hospital of Lishui City, The Third People's Hospital of Linfen City, Yibin First People's Hospital, Jingzhou Central Hospital, Wuxi Fifth People's Hospital, Qingyang People's Hospital, The First Affiliated Hospital of Anhui Medical University, Beilun Hospital of Traditional Chinese Medicine, Henan Provincial People's Hospital, Qingdao Sixth People's Hospital, The First Affiliated Hospital of Xiamen University, Shandong Provincial Hospital, Beijing YouAn Hospital, The First People's Hospital of Taicang, The Third People's Hospital of Taiyuan, Tianjin Second People's Hospital, Tianjin Third Central Hospital, Qishan Hospital of Yantai City, Affiliated Hospital of Yunnan University, The First People's Hospital of Yunnan, The Fourth Affiliated Hospital of Zhejiang University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Chongqing Medical University
COVID-19, Liver Disease, Vaccine Reaction
01/22
05/22
Wu, Wenjuan
NCT06038916: To Evaluate the Safety and Initial Efficacy of STSA-1002 Injection in Patients with Acute Respiratory Distress Syndrome

Recruiting
1/2
60
RoW
STSA-1002 Injection Placebo, STSA-1002 Injection
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Acute Respiratory Distress Syndrome
08/25
09/26
NCT05000671: A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome

Recruiting
1
16
RoW
STC314 injection or Placebo(rate=58.3 mg/hr), STC314 injection or Placebo(rate=87.5 mg/hr)
Grand Medical Pty Ltd., Grand Pharmaceutical (China) Co., Ltd.
Acute Respiratory Distress Syndrome
12/22
12/22
Hu, Xudong
TQ-A3334-II-03, NCT06706310: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection

Recruiting
2
116
RoW
Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Hepatitis B
12/25
06/26
NCT05867771: A Study of PM1022 in Patients With Advanced Tumors

Recruiting
1/2
200
RoW
PM1022
Biotheus Inc.
Advanced Tumors
04/24
04/25

Download Options